Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets
Open accessThe DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Abstract
Quinolinic acid (QUIN), a neuroactive metabolite of the kynurenine pathway, is normally presented in nanomolar concentrations in human brain and cerebrospinal fluid (CSF) and is often implicated in the pathogenesis of a variety of human neurological diseases. QUIN is an agonist of N-methyl-D-aspartate (NMDA) receptor, and it has a high in vivo potency as an excitotoxin. In fact, although QUIN has an uptake system, its neuronal degradation enzyme is rapidly saturated, and the rest of extracellular QUIN can continue stimulating the NMDA receptor. However, its toxicity cannot be fully explained by its activation of NMDA receptors it is likely that additional mechanisms may also be involved. In this review we describe some of the most relevant targets of QUIN neurotoxicity which involves presynaptic receptors, energetic dysfunction, oxidative stress, transcription factors, cytoskeletal disruption, behavior alterations, and cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, QUIN increases the release and blocks the reuptake of glutamate in astrocytes, thus increasing glutamatergic extracellular concentrations (132).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [132]
In the citing paper
“Together, this pathway may trigger hippocampal and mPFC cellular damage and volume reductions (138,144,145).”
From The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology (2019) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Cytokines and endothelial cell biology
Pober, J. S., & Cotran, R. S. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.427 · Cited by 1,242
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Schulze-Osthoff, K., Bakker, A. C., Vanhaesebroeck, B., Beyaert, R., Jacob, W. A., & Fiers, W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42768-8 · Cited by 939
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751 · cited 2×
“In 1981, Stone and Perkins discovered that QUIN was a potent excitant of neurons in the CNS, by acting as an agonist at the N-methyl-D-aspartate (NMDA) sensitive population glutamate receptors [29], and Schwarcz and coworkers (1983) were the first who demonstrated that QUIN causes selective neuronal lesions, and they…”
BackgroundKynurenine Pathway Metabolites in Humans: Disease and Healthy States
Chen, Y., & Guillemin, G. J. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2097 · Cited by 628
Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 3×
“As shown previously in cortical neurons, dopaminergic neurons do not produce QUIN but take it up from the microenvironment [15, 40].”
BackgroundHuman macrophages convert l-tryptophan into the neurotoxin quinolinic acid
Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 447
Connecting inflammation with glutamate agonism in suicidality
Erhardt, S., Lim, C. K., Linderholm, K. R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T. T., Träskman-Bendz, L., Guillemin, G. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.248 · Cited by 345
Portera-Cailliau, C., Price, D. L., & Martin, L. J. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970203)378:1<88::aid-cne5>3.0.co;2-g · Cited by 341
Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus
Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 330
Characterization of the Kynurenine Pathway in Human Neurons
Guillemin, G. J., Cullen, K. M., Lim, C. K., Smythe, G. A., Garner, B., Kapoor, V., Takikawa, O., & Brew, B. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4101-07.2007 · Cited by 324
Tavares, R. G., Tasca, C. I., Santos, C. E. S., Alves, L. B., Porciúncula, L. O., Emanuelli, T., & Souza, D. O. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00133-4 · Cited by 320
Quinolinic acid and other kynurenines in the central nervous system
Stone, T. W., & Connick, J. H. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90063-6 · Cited by 304
Cerebrospinal Fluid and Serum Markers of Inflammation in Autism
Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., & Heyes, M. P. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.03.014 · Cited by 300
Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O., Cohen, H., Lin, S. S., Manchester, J. K., Gordon, J. I., & Sinclair, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111773200 · Cited by 296
Kynurenine and its metabolites in Alzheimer's disease patients
Gulaj, E., Pawlak, K., Bien, B., & Pawlak, D. (2010) · Advances in Medical Sciences · doi:10.2478/v10039-010-0023-6 · Cited by 285
Polyamines reduces lipid peroxidation induced by different pro-oxidant agents
Bellé, N. A. V., Dalmolin, G. D., Fonini, G., Rubin, M. A., & Rocha, J. B. T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.036 · Cited by 262
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
GUIDETTI, P., LUTHICARTER, R., AUGOOD, S., & SCHWARCZ, R. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.006 · Cited by 260
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid
HEYES, M. P., ACHIM, C. L., WILEY, C. A., MAJOR, E. O., SAITO, K., & MARKEY, S. P. (1996) · Biochemical Journal · doi:10.1042/bj3200595 · Cited by 260
The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons
Rahman, A., Ting, K., Cullen, K. M., Braidy, N., Brew, B. J., & Guillemin, G. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006344 · Cited by 257
Differential vulnerability of central neurons of the rat to quinolinic acid
Schwarcz, R., & Köhler, C. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90115-5 · Cited by 239
Expression of The Kynurenine Pathway Enzymes in Human Microglia and Macrophages
Guillemin, G. J., Smith, D. G., Smythe, G. A., Armati, P. J., & Brew, G. J. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_12 · Cited by 229
Hayashi, M., Luo, Y., Laning, J., Strieter, R. M., & Dorf, M. E. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00064-9 · Cited by 226
Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons
Braidy, N., Grant, R., Adams, S., Brew, B. J., & Guillemin, G. J. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9051-z · Cited by 226
Behan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702940 · Cited by 225
Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types
HEYES, M. P., CHEN, C. Y., MAJOR, E. O., & SAITO, K. (1997) · Biochemical Journal · doi:10.1042/bj3260351 · Cited by 214
Wu, W., Nicolazzo, J. A., Wen, L., Chung, R., Stankovic, R., Bao, S. S., Lim, C. K., Brew, B. J., Cullen, K. M., & Guillemin, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059749 · Cited by 212
FOSTER, A. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90221-6 · Cited by 194
Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice
Lapin, I. P. (1978) · Journal of Neural Transmission · doi:10.1007/bf01262727 · Cited by 193
Spatial distribution of GABABR1 receptor mRNA and binding sites in the rat brain
Bischoff, S., Leonhard, S., Reymann, N., Schuler, V., Shigemoto, R., Kaupmann, K., & Bettler, B. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990913)412:1<1::aid-cne1>3.0.co;2-d · Cited by 176
Whetsell, W. O., & Schwarcz, R. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90609-5 · Cited by 175
Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes
Guillemin, G. J., Croitoru‐Lamoury, J., Dormont, D., Armati, P. J., & Brew, B. J. (2003) · Glia · doi:10.1002/glia.10175 · Cited by 173
Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice
Guidetti, P., Bates, G. P., Graham, R. K., Hayden, M. R., Leavitt, B. R., MacDonald, M. E., Slow, E. J., Wheeler, V. C., Woodman, B., & Schwarcz, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.011 · Cited by 166
Ting, K. K., Brew, B. J., & Guillemin, G. J. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-36 · Cited by 166
The quinolinic acid model of Huntington's disease: Locomotor abnormalities
Sanberg, P. R., Calderon, S. F., Giordano, M., Tew, J. M., & Norman, A. B. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90170-2 · Cited by 159
NAD+metabolism and oxidative stress: the golden nucleotide on a crown of thorns
Massudi, H., Grant, R., Guillemin, G. J., & Braidy, N. (2012) · Redox Report · doi:10.1179/1351000212y.0000000001 · Cited by 158 · cited 1×
“In mammals, about 90% of dietary TRP is metabolized along the kynurenine pathway (KP) (Figure 1) [1, 2], which represents the major catabolic route of TRP and a source of nicotinamide adenine nucleotide (NAD), a cofactor in cellular respiration and energy production that plays an important role in the DNA repair and t…”
BackgroundHeyes, M. P., Saito, K., Lackner, A., Wiley, C. A., Achim, C. L., & Markey, S. P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.881 · Cited by 153
Quinolinic acid induces oxidative stress in rat brain synaptosomes
Santamaría, A., Galván-Arzate, S., Lisý, V., Ali, S. F., Duhart, H. M., Osorio-Rico, L., Ríos, C., & Sut'astný, F. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00049 · Cited by 152
Self-citationInvolvement of quinolinic acid in aids dementia complex
Guillemin, G. J., Kerr, S. J., & Brew, B. J. (2005) · Neurotoxicity Research · doi:10.1007/bf03033781 · Cited by 145
de Carvalho, L. P., Bochet, P., & Rossier, J. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00091-7 · Cited by 144
The kynurenine pathway and inflammation in amyotrophic lateral sclerosis
Chen, Y., Stankovic, R., Cullen, K. M., Meininger, V., Garner, B., Coggan, S., Grant, R., Brew, B. J., & Guillemin, G. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9129-7 · Cited by 141 · cited 1×
“Amyotrophic lateral sclerosis ↑ in CSF and serum of patients (i) ↑ TRP and L-KYN, human leukocyte antigen-DR (ii) IDO over-expression [102]”
BackgroundHeyes, M. P., Brew, B. J., Saito, K., Quearry, B. J., Price, R. W., Lee, K., Bhalla, R. B., Der, M. G., & Markey, S. P. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90214-6 · Cited by 140
Wilt, S. G., Milward, E., Zhou, J. M., Nagasato, K., Patton, H., Rusten, R., Griffin, D. E., O'Connor, M., & Dubois‐Dalcq, M. (1995) · Annals of Neurology · doi:10.1002/ana.410370315 · Cited by 140
Aβ1-42 induces production of quinolinic acid by human macrophages and microglia
Guillemin, G. J., Smythe, G. A., Veas, L. A., Takikawa, O., & Brew, B. J. (2003) · NeuroReport · doi:10.1097/00001756-200312190-00005 · Cited by 137
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease
Wei, H., Qin, Z.-H., Senatorov, V. V., Wei, W., Wang, Y., Qian, Y., & Chuang, D.-M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00311-6 · Cited by 137
Guillemin, G. J., Wang, L., & Brew, B. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-16 · Cited by 135
Kerr, S. J., Armati, P. J., Guillemin, G. J., & Brew, B. J. (1998) · AIDS · doi:10.1097/00002030-199804000-00003 · Cited by 132
The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain
Moroni, F., Lombardi, G., Carla�, V., & Moneti, G. (1984) · Brain Research · doi:10.1016/0006-8993(84)90984-3 · Cited by 131
Apoptosis in substantia nigra following developmental striatal excitotoxic injury.
Macaya, A., Munell, F., Gubits, R. M., & Burke, R. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8117 · Cited by 129
Synthesis of Quinolinic Acid by 3‐Hydroxyanthranilic Acid Oxygenase in Rat Brain Tissue In Vitro
Foster, A. C., White, R. J., & Schwarcz, R. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb02826.x · Cited by 126
Silva‐Adaya, D., Cruz, V. P. L., Herrera‐Mundo, M. N., Mendoza‐Macedo, K., Villeda‐Hernández, J., BINIENDA, Z. K., Ali, S. F., & Santamaría, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05174.x · Cited by 125
Vazey, E. M., Chen, K. C., Hughes, S. M., & Connor, B. J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.034 · Cited by 124
Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum
Rodríguez-Martínez, E., Camacho‐Morales, A., Maldonado, P. D., Pedraza‐Chaverrí, J., Santamarı́a, D., Galván‐Arzate, S., & Santamaría, A. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02474-9 · Cited by 124
Self-citationLapin, L. P., Mirzaev, S., Ryzhov, I. V., & Oxenkrug, G. F. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00535.x · Cited by 121
Foster, A. C., Miller, L. P., Oldendorf, W. H., & Schwarcz, R. M. (1984) · Experimental Neurology · doi:10.1016/0014-4886(84)90239-5 · Cited by 116
Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain
Tavares, R. G., Tasca, C. I., Santos, C. E. S., Wajner, M., Souza, D. O., & Dutra-Filho, C. S. (2000) · NeuroReport · doi:10.1097/00001756-200002070-00005 · Cited by 116
Sadeghnia, H. R., Kamkar, M., Assadpour, E., Boroushaki, M. T., & Ghorbani, A. (2013) · PubMed Central · Cited by 116
Jeon, B. S., Kholodilov, N. G., Oo, T. F., Kim, S., Tomaselli, K. J., Srinivasan, A., Stefanis, L., & Burke, R. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730322.x · Cited by 114
Rossato, J. I., Zeni, G. R., Mello, C. F., Rubin, M. A., & da Rocha, J. B. T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02504-6 · Cited by 112
Hughes, P. E., Alexi, T., Yoshida, T., Schreiber, S. S., & Knüsel, B. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00174-1 · Cited by 110
Moroni, F., Lombardi, G., Moneti, G., & Aldinio, C. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90385-9 · Cited by 109
The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway.
Wolf, H. (1974) · PubMed · Cited by 109
Braidy, N., Grant, R., Adams, S., & Guillemin, G. J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07487.x · Cited by 108
In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum
Santamaría, A., Jiménez-Capdeville, M. E., Camacho, A., Rodríguez-Martínez, E., Flores, A., & Galván-Arzate, S. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00020 · Cited by 106
Santamaría, A., Salvatierra‐Sánchez, R., Vázquez‐Román, B., Santiago‐López, D., Villeda‐Hernández, J., Galván‐Arzate, S., Jiménez‐Capdeville, M. E., & Ali, S. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01857.x · Cited by 105
Misztal, M., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00682-6 · Cited by 103
Melatonin reduces oxidative neurotoxicity due to quinolinic acid:
Cabrera, J., Reiter, R. J., Tan, D. X., Qi, W., Sainz, R. M., Mayo, J. C., García, J. J., Kim, S. J., & El‐Sokkary, G. H. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00128-8 · Cited by 102
Energetic Dysfunction in Quinolinic Acid‐Lesioned Rat Striatum
Bordelon, Y. M., Chesselet, M., Nelson, D., Welsh, F., & Erecińska, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041629.x · Cited by 101
The effect of quinolinate on rat brain lipid peroxidation is dependent on iron
Štípek, S., Šťastný, F., Plátenı́k, J., Crkovska, J., & Zima, T. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(97)90002-4 · Cited by 97
Nakao, N., & Brundin, P. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00223-0 · Cited by 96
Mar�n, O., Smeets, W. J. A. J., & Gonz�lez, A. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970203)378:1<50::aid-cne3>3.0.co;2-j · Cited by 92
Noack, H., Lindenau, J., Rothe, F., Asayama, K., & Wolf, G. (1998) · Glia · doi:10.1002/(sici)1098-1136(199808)23:4<285::aid-glia1>3.0.co;2-2 · Cited by 90
Aspects of Disorders of the Kynurenine Pathway of Tryptophan Metabolism in Man
Musajo, L., & Benassi, C. A. (1964) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)60373-x · Cited by 85
Quinolinic acid: neurotoxicity
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08493.x · Cited by 84
Foster, A. C., Whetsell, W. O., Bird, E. D., & Schwarcz, R. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90647-x · Cited by 83
Braidy, N., Grant, R., Brew, B. J., Adams, S., Jayasena, T., & Guillemin, G. J. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2318 · Cited by 81
Pierozan, P., Zamoner, A., Soska, Â. K., Silvestrin, R. B., Loureiro, S. O., Heimfarth, L., Souza, T. M. E., Wajner, M., & Pessoa‐Pureur, R. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.009 · Cited by 80
Flanagan, E. M., Erickson, J. B., Viveros, O. H., Chang, S. Y., & Reinhard, J. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031192.x · Cited by 78
de la Cruz, V. P., González‐Cortés, C., Galván‐Arzate, S., Medina‐Campos, O. N., Pérez‐Severiano, F., Ali, S. F., Pedraza‐Chaverrí, J., & Santamaría, A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.027 · Cited by 77
Self-citationThe preferred route of kynurenine metabolism in the rat
Bender, D. A., & McCreanor, G. M. (1982) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(82)90379-8 · Cited by 76
Ribeiro, C. A. J., Grando, V., Dutra‐Filho, C. S., Wannmacher, C. M. D., & Wajner, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04199.x · Cited by 76
Quinolinic Acid Phosphoribosyltransferase in Rat Brain
Foster, A. C., Zinkand, W. C., & Schwarcz, R. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05435.x · Cited by 75
Kells, A., Henry, R. A., & Connor, B. J. (2008) · Gene Therapy · doi:10.1038/gt.2008.23 · Cited by 71
Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo
Connick, J. H., & Stone, T. W. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11474.x · Cited by 71
Chen, Y., Brew, B. J., & Guillemin, G. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07159.x · Cited by 68
Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity
Pérez-Severiano, F., Escalante, B., & Ríos, C. (1998) · Neurochemical Research · doi:10.1023/a:1020700401678 · Cited by 68
Self-citationPérez‐Navarro, E., Gavaldà, N., Gratacòs, E., & Alberch, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02904.x · Cited by 67
Wang, Y., Dong, X., Cao, Y., Liang, Z., Han, R., Wu, J., Gu, Z., & Qin, Z. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07025.x · Cited by 65
Shear, D. A., Dong, J., Haik-Creguer, K. L., Bazzett, T. J., Albin, R. L., & Dunbar, G. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6767 · Cited by 65
Quinolinic Acid and Active Oxygens
Goda, K., KISHIMOTO, R., Shimizu, S., Hamane, Y., & Ueda, M. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0381-7_38 · Cited by 64
Goda, K., KISHIMOTO, R., Shimizu, S., Hamane, Y., & Ueda, M. (1996) · PubMed · Cited by 63
Kalonia, H., Kumar, P., Kumar, A., & Nehru, B. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.039 · Cited by 61
Beagles, K. E., Morrison, P. F., & Heyes, M. P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010281.x · Cited by 59
Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats
Leipnitz, G., Schumacher, C., Scussiato, K., Dalcin, K. B., Wannmacher, C. M. D., Wyse, Â. T. D. S., Dutra‐Filho, C. S., Wajner, M., & Latini, A. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.08.004 · Cited by 58
Iwahashi, H., Kawamori, H., & Fukushima, K. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00080-0 · Cited by 56
Hanbury, R., Ling, Z. D., Wuu, J., & Kordower, J. H. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10667 · Cited by 54
Kalonia, H., Kumar, P., & Kumar, A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.04.018 · Cited by 54
Tronel, C., Rochefort, G. Y., Arlicot, N., Bodard, S., Chalon, S., & Antier, D. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/264935 · Cited by 52
Kohler, C., Eriksson, L., Flood, P., Hardie, J., Okuno, E., & Schwarcz, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-03-00975.1988 · Cited by 47
Pierozan, P., Zamoner, A., Soska, Â. K., de Lima, B. O., Reis, K. P., Zamboni, F., Wajner, M., & Pessoa‐Pureur, R. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.005 · Cited by 47
Oligodendrocyte killing by quinolinic acid in vitro
Cammer, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02017-0 · Cited by 47
Effects of Nω-nitro-L-arginine and L-arginine on quinolinic acid-induced lipid peroxidation
Santamarı́a, A., Santamarı́a, D., Díaz‐Muñoz, M., Espinoza-González, V., & Rı́os, C. (1997) · Toxicology Letters · doi:10.1016/s0378-4274(97)00082-9 · Cited by 44
Self-citationExpression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid
Schiefer, J., Töpper, R., Schmidt, W., Block, F., Heinrich, P. C., Noth, J., & Schwarz, M. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00133-7 · Cited by 42
de la Cruz, V. P., Elinos, D., Robledo-Arratia, Y., Medina‐Campos, O. N., Pedraza‐Chaverrí, J., Ali, S. F., & Santamaría, A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.037 · Cited by 40
Self-citationIshidoh, K., Kamemura, N., Imagawa, T., Oda, M., Sakùrai, J., & Katunuma, N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.02.007 · Cited by 40
Qin, Z.-H., Wang, Y., & Chasea, T. N. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00147-9 · Cited by 39
The mechanism of inhibition of phosphoenolpyruvate carboxylase by quinolinic acid
McDaniel, H. G., Reddy, W. J., & Boshell, B. R. (1972) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(72)91015-7 · Cited by 39
Espey, M. G., Moffett, J. R., & Namboodiri, M. A. A. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.2.199 · Cited by 35
Ganzella, M., Jardim, F. M. A., Boeck, C. R., & Vendite, D. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.05.003 · Cited by 34
Rc, R., McCarthy, K., Du, F., Ottersen, O. P., Okuno, E., & Schwarcz, R. M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01150.1995 · Cited by 33
de la Cruz, V. P., Königsberg, M., Pedraza‐Chaverrí, J., Herrera‐Mundo, N., Díaz‐Muñoz, M., Morán, J., van der Goes, T. I. F., Rondán-Zarate, A., Maldonado, P. D., Ali, S. F., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06088.x · Cited by 33
Self-citationMelatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus
Southgate, G., Daya, S., & Potgieter, B. (1998) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(98)00026-x · Cited by 33
Wilhelm, E. A., Jessé, C. R., Bortolatto, C. F., & Nogueira, C. W. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.007 · Cited by 33
Kalonia, H., Kumar, P., & Kumar, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.01.003 · Cited by 32
Kalonia, H., & Kumar, A. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.02.020 · Cited by 30
Kalonia, H., Kumar, P., Kumar, A., & Nehru, B. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2009.12.008 · Cited by 30
McGeer, E. G., & Singh, E. A. (1984) · Experimental Neurology · doi:10.1016/0014-4886(84)90197-3 · Cited by 30
Santamaría, A., Vázquez‐Román, B., de la Cruz, V. P., González‐Cortés, C., Trejo‐Solís, C., Galván‐Arzate, S., Jara‐Prado, A., Fonseca, J. G., & Ali, S. F. (2005) · Synapse · doi:10.1002/syn.20206 · Cited by 29
de la Cruz, V. P., Elinos, D., Carrillo‐Mora, P., Silva‐Adaya, D., Königsberg, M., Morán, J., Ali, S. F., Chánez‐Cárdenas, M. E., de la Cruz, G. P., & Santamaría, A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.008 · Cited by 29
In vitro effect of quinolinic acid on energy metabolism in brain of young rats
Schuck, P. F., Tonin, A. M., Ferreira, G. C., Rosa, R. B., Latini, A., Balestro, F., Perry, M. L. S., Wannmacher, C. M. D., Wyse, Â. T. D. S., & Wajner, M. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.10.013 · Cited by 28
A radioenzymatic assay for quinolinic acid
Foster, A. C., Okuno, E., Brougher, D. S., & Schwarcz, R. M. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90595-6 · Cited by 28
Glutamine synthesis from aspartate in guinea-pig renal cortex
Baverel, G., Martin, G., & Michoudet, C. (1990) · Biochemical Journal · doi:10.1042/bj2680437 · Cited by 28
The Ayurvedic drug, Ksheerabala, ameliorates quinolinic acid-induced oxidative stress in rat brain
Indira, M., & Swathy, S. (2010) · International Journal of Ayurveda Research · doi:10.4103/0974-7788.59936 · Cited by 26
Füvesi, J., Rajda, C., Bencsik, K., Toldi, J., & Vécsei, L. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0765-3 · Cited by 25
Kalonia, H., Kumar, P., Kumar, A., & Nehru, B. (2009) · Neuroscience Bulletin · doi:10.1007/s12264-009-0513-3 · Cited by 24
Bordelon, Y. M., Chesselet, M., Erecińska, M., & Silver, I. A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00421-1 · Cited by 23
Kalonia, H., Kumar, P., Nehru, B., & Kumar, A. (2009) · PubMed · Cited by 23
Block, F., & Schwarz, M. (1994) · Neuroreport · doi:10.1097/00001756-199411000-00008 · Cited by 22
Maldonado, P. D., de la Cruz, V. P., Torres-Ramos, M., Silva‐Islas, C. A., Lecona-Vargas, R., Lugo-Huitrón, R., Ayala, T. B., Ugalde‐Muñiz, P., Vázquez-Cervantes, G. I., van der Goes, T. I. F., et al. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.004 · Cited by 22
Self-citationQuinolinic Acid and Inflammation
Heyes, M. P. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb18300.x · Cited by 21
Müller, A. C., Dairam, A., Limson, J. L., & Daya, S. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.11.031 · Cited by 20
Quinolinate-induced Rat Striatal Excitotoxicity Impairs Endoplasmic Reticulum Ca2+-ATPase Function
Fernandes, A. M. A. P., Landeira-Fernandez, A. M., Souza-Santos, P., Carvalho-Alves, P. C., & Castilho, R. F. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9619-7 · Cited by 20
Quinolinic acid protects rat cerebellar granule cells from glutamate-induced apoptosis
Sei, Y., Fossom, L. H., Goping, G., Skolnick, P., & Basile, A. S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00980-4 · Cited by 20
Elinos, D., Robledo-Arratia, Y., de la Cruz, V. P., Pedraza‐Chaverrí, J., Ali, S. F., & Santamaría, A. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1913-3 · Cited by 20
Self-citationStachowski, E. K., & Schwarcz, R. M. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0694-6 · Cited by 20
The effect of quinolinate on rat brain lipid peroxidation is dependent on iron
típek, S. (1996) · Neurochemistry International · doi:10.1016/s0197-0186(96)00067-8 · Cited by 19
Naoi, M., Ishiki, R., Nomura, Y., Hasegawa, S., & Nagatsu, T. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90155-8 · Cited by 18
Dairam, A., Chetty, P., & Daya, S. (2006) · Metabolic Brain Disease · doi:10.1007/s11011-006-9014-5 · Cited by 18
Dairam, A., Müller, A. C., & Daya, S. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.006 · Cited by 17
Santiago‐López, D., Vázquez‐Román, B., de la Cruz, V. P., Barrera, D., Rembao, D., Salinas‐Lara, C., Pedraza‐Chaverrí, J., Galván‐Arzate, S., Ali, S. F., & Santamaría, A. (2004) · Synapse · doi:10.1002/syn.20084 · Cited by 17
Self-citationBordelon, Y. M., Mackenzie, L., & Chesselet, M.-F. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990913)412:1<38::aid-cne3>3.0.co;2-6 · Cited by 15
Aciclovir protects against quinolinic-acid-induced oxidative neurotoxicity
Müller, A. C., Maharaj, H., Maharaj, D. S., & Daya, S. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357056442 · Cited by 13
Iron porphyrinate Fe(TPPS) reduces brain cell damage in rats intrastriatally lesioned by quinolinate
González‐Cortés, C., Salinas‐Lara, C., Gómez-López, M. A., Tena‐Suck, M. L., de la Cruz, V. P., Rembao‐Bojórquez, D., Pedraza‐Chaverrí, J., Gómez-Ruíz, C., Galván‐Arzate, S., Ali, S. F., et al. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2008.05.004 · Cited by 7
Self-citationKalonia, H., & Kumar, A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70318-2 · Cited by 1
Research works printed but not linked: 10
- 1974, Scandinavian Journal of Clinical and Laboratory Investigation, 136, 1
- 2009, International Journal of Tryptophan Research, 2, 61
- 1993, Pharmacological Reviews, 45, 309
- 2009, International Journal of Tryptophan Research, 2, 1
- 2012, Effect of some kynurenines under succinate deshidrogenase activity and ATP production: in vitro experimental and computational tools, 60.09
- 2013, European Journal of Pharmacology, 701, 65
- 2009, Indian Journal of Experimental Biology, 47, 880
- 2006, Metabolic Brain Disease, 21, 221
- 2013, Iranian Journal of Basic Medical Sciences, 16, 73
- 2013, PloS One, 8
Cited by
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/360438 · Cited by 6,349
Santomasso, B. D., Park, J. H., Salloum, D., Riviere, I., Flynn, J., Mead, E., Halton, E., Wang, X., Senechal, B., Purdon, T., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1319 · Cited by 942
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“Moreover, QUIN increases the release and blocks the reuptake of glutamate in astrocytes, thus increasing glutamatergic extracellular concentrations (132).”
BackgroundBelleau, E. L., Treadway, M. T., & Pizzagalli, D. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.031 · Cited by 550
“Together, this pathway may trigger hippocampal and mPFC cellular damage and volume reductions (138,144,145).”
Inflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 382
Metadata
- Authors
- Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V.
- Affiliations
- Instituto Nacional de Neurología y Neurocirugía (MX)
- Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Insurgentes Sur 3877, S.S.A., 14269 México, DF, Mexico
- Laboratorio de Neuroinmunología, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Insurgentes Sur 3877, S.S.A., 14269 México, DF, Mexico
- Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-14
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC3780648
- OpenAlex
- W1991576487
- Cited by
- 394
- References
- 146
- Citations by year
- 2026: 44 · 2025: 48 · 2024: 50 · 2023: 41 · 2022: 54 · 2021: 42 · 2020: 23 · 2019: 17 · 2018: 16 · 2017: 23 · 2016: 21 · 2015: 11 · 2014: 4
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Consejo Nacional de Ciencia y Tecnología (183867)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- quinolinic acid, kynurenine pathway, neurotoxicity, excitotoxicity, presynaptic receptors, oxidative stress, transcription factors, cytoskeleton disruption, behavioral alterations, neuronal cell death, neurological disorders
- MeSH terms
- Animals, Energy Metabolism, Humans, Inflammation, Neurotoxins, Quinolinic Acid, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.